CDK6: an attractive therapeutic target for T-ALL/LBL

.

Source: Expert Opinion on Therapeutic Targets - November 17, 2023 Category: Drugs & Pharmacology Authors: Wei LiJamie Katy HuMiaofen G Hua Department of Medicine, Division of Hematology and Oncology, Tufts Medical Center, Boston, USAb Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, U Source Type: research